Search Results - "Mozo, Paloma Campo"
-
1
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Published in The lancet respiratory medicine (01-03-2021)“…ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exacerbation rate, lung…”
Get full text
Journal Article Web Resource -
2
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-07-2021)“…There is a lack of tools to quantify the response to monoclonal antibodies (mAbs) holistically in severe uncontrolled asthma patients. To develop a valid score…”
Get full text
Journal Article -
3
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Published in The lancet respiratory medicine (01-03-2021)Get full text
Journal Article -
4
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV 1 , Exacerbations, Oral Corticosteroids, Symptoms Score
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-07-2021)“…There is a lack of tools to quantify the response to monoclonal antibodies (mAbs) holistically in severe uncontrolled asthma patients. To develop a valid score…”
Get full text
Journal Article